Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Translate Bio has reported that its Covid-19 vaccine candidate, being developed in collaboration with Sanofi, elicited immune response in early-stage animal studies.
In a regulatory filing, Translate Bio cited Sanofi’s presentation slides, which revealed that three doses of the vaccine candidate triggered neutralising antibodies and T-cell responses in the preclinical tests.